J Nanosci Nanotechnol:改性氧化锆可增强成骨

2019-08-12 不详 网络

氧化锆(Zr)也被称为生物相容性材料,具有有利的机械性能以及低的斑块粘附性。在该研究中,我们检查了通过点击反应结合的生长和分化因子-5(GDF-5)包被的Zr作为底物的功效,以促进MC3T3-E1细胞的成骨分化。通过扫描电子显微镜(SEM)和X射线光电子能谱(XPS)表征原始和表面改性的Zr表面,使得GDF-5成功地涂覆到原始Zr表面上。涂覆在Zr表面上的GDF-5以持续的方式释放28天。GDF-

氧化锆(Zr)也被称为生物相容性材料,具有有利的机械性能以及低的斑块粘附性。在该研究中,我们检查了通过点击反应结合的生长和分化因子-5(GDF-5)包被的Zr作为底物的功效,以促进MC3T3-E1细胞的成骨分化。

通过扫描电子显微镜(SEM)和X射线光电子能谱(XPS)表征原始和表面改性的Zr表面,使得GDF-5成功地涂覆到原始Zr表面上。涂覆在Zr表面上的GDF-5以持续的方式释放28天。GDF-5包被的Zr(Zr / GDF-5)表面上的新骨形成通过体外试验证实,包括细胞增殖,碱性磷酸酶活性和钙沉积试验,实时聚合酶链反应(qPCR)试验显示osterix(OSX),runt相关转录因子2(Runx 2),COL 1(I型胶原)和骨钙蛋白(OC)的表达升高。当细胞在Zr/GDF-5上培养时,MC3T3-E1细胞的细胞增殖,碱性磷酸酶活性和钙沉积显著增强。此外,qPCR的结果显示,当细胞在Zr/GDF-5上培养时,与成骨分化相关的基因被上调。

综上所述,该研究结果表明,Zr/GDF-5可用作增强成骨分化的材料。

原始出处:

Yoon SJ, Yang DH, et al., In Vitro Osteogenic Differentiation Enhanced by Zirconia Coated with Nano-Layered Growth and Differentiation Factor-5. J Nanosci Nanotechnol. 2016 Jan;16(1):280-6.

评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1652363, encodeId=a4ef165236353, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17245, encryptionId=13d01e24509, topicName=TEC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=852f24292001, createdName=shock_melon, createdTime=Tue Dec 10 05:44:00 CST 2019, time=2019-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1352200, encodeId=12fd1352200b4, content=<a href='/topic/show?id=e95954093cd' target=_blank style='color:#2F92EE;'>#成骨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54093, encryptionId=e95954093cd, topicName=成骨)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Aug 14 13:44:00 CST 2019, time=2019-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1459766, encodeId=0c731459e6609, content=<a href='/topic/show?id=00da63996ea' target=_blank style='color:#2F92EE;'>#氧化锆#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63996, encryptionId=00da63996ea, topicName=氧化锆)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=facd6195692, createdName=medsci248, createdTime=Wed Aug 14 13:44:00 CST 2019, time=2019-08-14, status=1, ipAttribution=)]
    2019-12-10 shock_melon

    #TEC#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1652363, encodeId=a4ef165236353, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17245, encryptionId=13d01e24509, topicName=TEC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=852f24292001, createdName=shock_melon, createdTime=Tue Dec 10 05:44:00 CST 2019, time=2019-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1352200, encodeId=12fd1352200b4, content=<a href='/topic/show?id=e95954093cd' target=_blank style='color:#2F92EE;'>#成骨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54093, encryptionId=e95954093cd, topicName=成骨)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Aug 14 13:44:00 CST 2019, time=2019-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1459766, encodeId=0c731459e6609, content=<a href='/topic/show?id=00da63996ea' target=_blank style='color:#2F92EE;'>#氧化锆#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63996, encryptionId=00da63996ea, topicName=氧化锆)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=facd6195692, createdName=medsci248, createdTime=Wed Aug 14 13:44:00 CST 2019, time=2019-08-14, status=1, ipAttribution=)]
    2019-08-14 zhaojie88

    #成骨#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1652363, encodeId=a4ef165236353, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17245, encryptionId=13d01e24509, topicName=TEC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=852f24292001, createdName=shock_melon, createdTime=Tue Dec 10 05:44:00 CST 2019, time=2019-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1352200, encodeId=12fd1352200b4, content=<a href='/topic/show?id=e95954093cd' target=_blank style='color:#2F92EE;'>#成骨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54093, encryptionId=e95954093cd, topicName=成骨)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Aug 14 13:44:00 CST 2019, time=2019-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1459766, encodeId=0c731459e6609, content=<a href='/topic/show?id=00da63996ea' target=_blank style='color:#2F92EE;'>#氧化锆#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63996, encryptionId=00da63996ea, topicName=氧化锆)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=facd6195692, createdName=medsci248, createdTime=Wed Aug 14 13:44:00 CST 2019, time=2019-08-14, status=1, ipAttribution=)]
    2019-08-14 medsci248

    #氧化锆#

    0